Financials data is unavailable for this security.
View more
Year on year agilon health inc had net income fall 146.45% from a loss of 106.55m to a larger loss of 262.60m despite a 80.74% increase in revenues from 2.39bn to 4.32bn. An increase in the cost of goods sold as a percentage of sales from 87.67% to 92.87% was a component in the falling net income despite rising revenues.
| Gross margin | 2.00% |
|---|---|
| Net profit margin | -5.73% |
| Operating margin | -6.42% |
| Return on assets | -14.04% |
|---|---|
| Return on equity | -42.40% |
| Return on investment | -36.97% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at agilon health inc fell by 393.35m. Cash Flow from Investing was negative at 44.02m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 156.20m for operations while cash used for financing totalled 193.13m.
| Cash flow per share | -0.7023 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.40 |
|---|---|
| Tangible book value per share | 1.16 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.29 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0607 |
|---|---|
| Total debt/total capital | 0.0572 |
More ▼
